Thomas Anthony Hunt

This inventor holds 3 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Astrazeneca Ab. Active years: 2019-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Anthony Hunt. Retrieved from https://idiyas.com/inventor/thomas-anthony-hunt-3n0yphov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 4.0

ph-index = 1

Company Filing History:

3 out of 1,534

Astrazeneca Ab

patents

Years Active: 2019-2023

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11613539 - Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer (2023-03-28),

2. 10882858 - Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer (2021-01-05),

3. 10457679 - Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer (2019-10-29),

Title: Innovator in Cancer Research - Thomas Anthony Hunt

Introduction

Thomas Anthony Hunt, a prominent inventor based in Cambridge, GB, has made significant contributions to the field of cancer research through his innovative work. With a total of three patents to his name, he has focused on developing novel compounds that hold potential therapeutic benefits.

Latest Patents

Hunt's latest patents include the groundbreaking discoveries of Imidazo[4,5-c]quinolin-2-one compounds, which are tailored for use in treating cancer. The specifications of these patents generally relate to compounds of a specific formula that may play a crucial role in the advancement of cancer treatment options.

Career Highlights

Currently, Thomas Anthony Hunt works at AstraZeneca AB, a leading global biopharmaceutical company dedicated to the discovery and development of innovative medicines. His work at AstraZeneca has allowed him to explore and develop promising therapeutic compounds, contributing greatly to the company's portfolio and overall mission.

Collaborations

Throughout his career, Hunt has collaborated with esteemed colleagues such as Bernard Barlaam and Kurt G. Pike. These partnerships have fostered an environment of innovation and creativity, leading to successful outcomes in their collective research endeavors.

Conclusion

Thomas Anthony Hunt stands as a significant figure in the realm of cancer research, combining his expertise and collaborative efforts to develop groundbreaking treatments. His ongoing contributions reflect the essence of innovation in medical science, paving the way for future advancements in healthcare.

Profile summary based on public USPTO records.